Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma.
暂无分享,去创建一个
G. Valdivia | R. Perez-Padilla | A. Menezes | F. Wehrmeister | M. Montes de Oca | Gilbert Nadeau | Rogelio Pérez-Padilla | J. Jardim | A. Muiño | C. Tálamo | Maria Montes de Oca | Ana Maria B. Menezes | Fernando César Wehrmeister | Maria Victorina Lopez-Varela | Adriana Muiño | José Roberto B. Jardim | Gonzalo Valdivia | Carlos Tálamo | G. Nadeau | M. López-Varela | Adriana Muiño
[1] G. Valdivia,et al. Diagnostic labeling of COPD in five Latin American cities. , 2007, Chest.
[2] N. Anthonisen,et al. Prevalence of asthma symptoms among adults aged 20-44 years in Canada. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[3] E. Rönmark,et al. The costs of exacerbations in chronic obstructive pulmonary disease (COPD). , 2002, Respiratory medicine.
[4] T. Haahtela,et al. Overlap Syndrome of Asthma and COPD Predicts Low Quality of Life , 2011, The Journal of asthma : official journal of the Association for the Care of Asthma.
[5] Cesar G Victora,et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study , 2005, The Lancet.
[6] T L Petty,et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. , 2000, Archives of internal medicine.
[7] R. de Marco,et al. The Coexistence of Asthma and Chronic Obstructive Pulmonary Disease (COPD): Prevalence and Risk Factors in Young, Middle-aged and Elderly People from the General Population , 2013, PloS one.
[8] J. Soriano,et al. Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. , 2013, Respiratory medicine.
[9] Shengming Liu,et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. , 2007, American journal of respiratory and critical care medicine.
[10] Joan B Soriano,et al. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. , 2003, Chest.
[11] Edwin K Silverman,et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. , 2010, American journal of respiratory and critical care medicine.
[12] D. Mannino,et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study , 2007, The Lancet.
[13] A L Hansell,et al. Proportional classifications of COPD phenotypes , 2008, Thorax.
[14] R. Buhl,et al. Clinical application of a simple questionnaire for the differentiation of asthma and chronic obstructive pulmonary disease. , 2004, Respiratory medicine.
[15] D. Jarvis,et al. Physician-diagnosed asthma and drug utilization in the European Community Respiratory Health Survey. , 1997, The European respiratory journal.
[16] J. Jardim,et al. Valores de referencia espirométrica en 5 grandes ciudades de Latinoamérica para sujetos de 40 o más años de edad , 2006 .
[17] J C Jager,et al. Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands. , 1999, Respiratory medicine.
[18] D. Maldonado,et al. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). , 2008, Chest.
[19] E. Antón,et al. Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD). , 2013, Respiratory medicine.
[20] C. Victora,et al. The Platino project: methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities , 2004, BMC medical research methodology.
[21] S. Tortolero,et al. Prevalence and risk factors of asthma and wheezing among US adults: an analysis of the NHANES III data , 2003, European Respiratory Journal.
[22] D. Jarvis,et al. Variation in bronchial responsiveness in the European Community Respiratory Health Survey (ECRHS). , 1997, The European respiratory journal.
[23] Deborah Jarvis,et al. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). , 1996, The European respiratory journal.
[24] G. Valdivia,et al. [Spirometric reference values in 5 large Latin American cities for subjects aged 40 years or over]. , 2006, Archivos de bronconeumologia.
[25] John L. Hankinson,et al. Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.
[26] R. Pauwels,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.
[27] M. Malesker,et al. Pharmacoeconomic evaluation of COPD. , 2000, Chest.
[28] Joyce D. Schroeder,et al. The clinical features of the overlap between COPD and asthma , 2011, Respiratory research.
[29] L. Punnett,et al. National income, self-reported wheezing and asthma diagnosis from the World Health Survey , 2009, European Respiratory Journal.
[30] P. J. Barnes,et al. Global strategy for asthma management and prevention: GINA executive summary , 2008, European Respiratory Journal.
[31] Ramon Gisbert,et al. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. , 2002, Chest.